Median survival (months)a | 5-year OS rate (%) | P value | |
---|---|---|---|
Age (yr) | |||
≦60 | 28.96 ± 3.98 (21.165 to 36.755) | 40.4 | 0.338 |
>60 | 15.02 ± 19.37 (0 to 52.977) | 34.6 | |
Gender | |||
Male | 22.68 ± 5.44 (12.020 to 33.340) | 30.1 | 0.068 |
Female | 28.14 ± 6.45 (15.491 to 40.789) | 62.5 | |
Alcohol | |||
Yes | 19.40 ± 7.87 (3.968 to 34.832) | 18.5 | 0.027 |
No | 47.08 ± 32.31 (0 to 110.413) | 46.6 | |
Hepatitis B virus | |||
Positive | 28.96 ± 3.74 (21.630 to 36.290) | 40.3 | 0.332 |
Negative | 17.72 ± 3.66 (10.556 to 24.884) | 32.7 | |
Hepatitis C virus | |||
Positive | 47.08 ± 38.99 (0 to 123.488) | 41.7 | 0.665 |
Negative | 28.14 ± 5.04 (18.265 to 38.015) | 37.2 | |
Preoperativeα-fetoprotein (ng/ml) | |||
≦20 | 61.91 ± 31.65 (0 to 123.934) | 51.3 | 0.847 |
>20 | 27.88 ± 6.69 (14.772 to 40.988) | 33.4 | |
Child-Pugh classification | |||
A | 28.96 ± 7.08 (15.086 to 42.834) | 38.7 | 0.461 |
B | 19.40 ± 0 (−− to --) | 0 | |
Size (cm) | |||
≦5 | 61.91 ± 34.99 (0 to 130.486) | 58.3 | 0.310 |
>5 | 22.68 ± 5.46 (11.988 to 33.372) | 30.7 | |
Encapsulation | |||
Yes | 47.08 ± 28.79 (0 to 103.515) | 48.6 | 0.122 |
No | 19.10 ± 3.34 (12.551 to 25.649) | 28.6 | |
Tumor rupture | |||
Yes | 27.88 ± 4.99 (18.105 to 37.655) | 32.9 | 0.206 |
No | 80.55 ± 46.93 (0 to 172.539) | 75.0 | |
Vascular invasion | |||
Yes | 17.72 ± 4.26 (9.373 to 26.067) | 9.0 | 0.005 |
No | 61.91 ± 31.46 (0.240 to 123.58) | 51.3 | |
Daughter nodules | |||
Yes | 17.72 ± 8.14 (1.760 to 33.680) | 10.8 | |
No | 47.08 ± 26.69 (0 to 98.611) | 48.6 | 0.009 |
Resection margin | |||
Positive | 7.63 ± 2.17 (3.379 to 11.881) | 20.0 | 0.029 |
Negative | 32.71 ± 9.00 (15.067 to 50.353) | 40.1 | |
Liver cirrhosis | |||
Positive | 28.96 ± 8.66 (11.981 to 45.939) | 41.0 | 0.791 |
Negative | 22.68 ± 9.37 (4.322 to 41.038) | 33.3 | |
Edmonson and Steiner grade | |||
I | 36.91 ± 36.64 (0 to 133.736) | 60.0 | 0.063 |
II | 80.55 ± 32.99 (15.895 to 145.205) | 60.0 | |
III | 22.68 ± 5.46 (11.978 to 33.382) | 24.2 | |
IV | 17.72 ± 3.20 (11.443 to 23.997) | 0 | |
Stage | |||
I | 101.98 ± 0 (−− to --) | 55.6 | 0.020 |
II | 61.91 ± 22.30 (18.198 to 105.622) | 75.0 | |
III | 19.40 ± 3.33 (12.873 to 25.927) | 22.5 | |
IV | 11.34 ± 6.12 (0 to 23.326) | 0 | |
CK19 liver b | |||
Positive | 9.37 ± 3.28 (2.942 to 15.798) | 11.1 | 0.026 |
Negative | 28.96 ± 20.96 (0 to 70.039) | 45.8 | |
CK19 LN c | |||
Positive | 9.37 ± 3.17 (3.165 to 15.575) | 0 | 0.007 |
Negative | 28.96 ± 12.92 (3.642 to 54.278) | 43.3 |